SIM
TARA icon

Spark Investment Management’s Protara Therapeutics TARA Stock Holding History

Spark Investment Management’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-288
Closed -$107K – 871
2016
Q3 		$107K Buy
+288
New +$101K 0.01% 743
2015
Q3 		– Sell
-378
Closed -$269K – 744
2015
Q2 		$269K Buy
+378
New +$234K 0.04% 466

Other funds holding TARA

A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PI
Pharmstandard International Luxembourg $29M AUM 3.25% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
FCI
Financial Counselors Inc Overland Park, Kansas $70.9M AUM 16.78% 1-Year Est. Return

Spark Investment Management's TARA Position: Q4 2016 in Review

Spark Investment Management sold out of Protara Therapeutics (TARA) in Q4 2016, closing a stake of 288 shares — an estimated $107K sold.

Spark Investment Management first reported a position in TARA in Q2 2015 and held it in 2 quarters. The position peaked at $269K in Q2 2015. 25 funds tracked by Wall St. Rank hold TARA as of Q4 2016.

  • Spark Investment Management reported no remaining Protara Therapeutics position as of Q4 2016 after selling out during the quarter.
  • Spark Investment Management sold 288 Protara Therapeutics shares in Q4 2016, an estimated $107K.
  • Spark Investment Management first reported a position in Protara Therapeutics in Q2 2015 and held it in 2 quarters.
  • Spark Investment Management's Protara Therapeutics position peaked at $269K in Q2 2015.
  • 25 funds tracked by Wall St. Rank held Protara Therapeutics as of Q4 2016.

Based on Spark Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.